{"symbol":"ABT","fiscalQuarter":"Q2-2023","reportDate":"2023-07-20","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q2-2023","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Up 4.24%","keyNumbers":[{"metric":"EPS","actual":"$1.08","expected":"N/A","surprise":"+3.55%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No forward guidance data is available.","changes":[]},"whatItMeans":"Abbott Laboratories reported a better-than-expected EPS for Q2 2023, which contributed to a positive stock reaction, with shares rising by 4.24%. However, there was no revenue figure provided, leaving some uncertainty about overall performance. The lack of guidance and management commentary means investors will need to wait for further information to assess future prospects.","metaDescription":"Abbott Laboratories (ABT) Q2 2023 earnings: EPS beat by 3.55%. Stock up 4.24%. Full breakdown."}}